临床肿瘤学杂志

• 综述与讲座 • 上一篇    下一篇

Toll样受体在乳腺癌中的研究进展

曹彩红,赵曙综述,张清媛   

  1. 哈尔滨医科大学附属肿瘤医院内三科
  • 收稿日期:2013-03-10 修回日期:2013-06-11 出版日期:2013-12-31 发布日期:2013-12-31
  • 通讯作者: 张清媛

Progression of toll-like receptors in breast cancer

CAO Caihong,ZHAO Shu,ZHANG Qingyuan   

  1. the Third Department of Internal Medicine, the Affiliated Tumor Hospital of Harbin Medical University
  • Received:2013-03-10 Revised:2013-06-11 Online:2013-12-31 Published:2013-12-31
  • Contact: ZHANG Qingyuan

摘要: Toll样受体(TLRs)是天然免疫系统中特异的Ⅰ型跨膜受体及病原体模式识别受体,在急性炎症反应、细胞信号转导和细胞凋亡中起重要作用。近几年来发现多种肿瘤细胞表达TLR,其中乳腺癌细胞表达TLR3、TLR4、TLR5和TLR9。有些TLR可能与乳腺癌的免疫逃逸和肿瘤进展相关,而有些TLR则可能参与了抗肿瘤作用。本文就乳腺癌细胞表达的常见几种TLR及其相关信号传导通路作如下综述。

Abstract: Tolllike receptors are the specific type Ⅰ transmembrane receptors and pathogen pattern recognition receptors in the innate immune system and play an important role in acute inflammatory response,cellular signal transduction and apoptosis. Recent research indicate that many kinds of tumor cells express several TLRs. Some may be related to immune escape and tumor progression, but others may be involved in the antitumor immune responses. In this review,we summarize the main TLRs known to be expressed by breast cancer cells and their associated signal transduction pathways.

No related articles found!
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed   
No Suggested Reading articles found!